Link to scroll to top of page

Top Performing Mid Cap Stocks 2024

Best Mid Cap Stocks in 2024, By Price History

Sectors & Industries

Table of Contents

Mid-cap stocks shined in 2024, offering a unique mix of steady growth and innovation. They combine the agility of smaller firms with the stability of larger ones, making them an appealing choice for investors seeking balanced opportunities.

Here are the Top Performing Mid Cap Stocks 2024

GeneDx Holdings Corp (WGS) - YTD Stock Price Performance: +2690%

GeneDx
Source: Seeking Alpha
  • Market Cap: $2.05B
  • Current Price: $73.5
  • Revenue Growth Quarterly (Y/Y): 44.22%
  • Operating Expense Growth Quarterly (Y/Y): -5.64%
  • Net Income: -8.31M
  • Net Profit Margin Quarterly (Y/Y): 86.37%
  • Earnings per Share (EPS): $0.04
  • EBITDA: -1.85M
  • Effective Tax Rate: 0.56%

GeneDx Holdings saw remarkable performance in 2024, bolstered by advances in its genetic testing technologies and strategic partnerships. Its focus on precision medicine significantly contributed to its revenue growth.

Sezzle Inc (SEZL) - YTD Stock Price Performance: +1370%

Sezzle's Zip
Source: Reuters

  • Market Cap: $1.78B
  • Current Price: $315
  • Revenue Growth Quarterly (Y/Y): 71.28%
  • Operating Expense Growth Quarterly (Y/Y): -3.50%
  • Net Income: 15.45M
  • Net Profit Margin Quarterly (Y/Y) : 596.53%
  • Earnings per Share (EPS): $2.92
  • EBITDA: 36.48M
  • Effective Tax Rate: 12.28%
  • P/E Ratio: 33.51

As a leader in the Buy-Now-Pay-Later (BNPL) space, Sezzle saw significant growth due to an increased user base and expanded partnerships with major retailers.

Longboard Pharmaceuticals Inc (LBPH) - YTD Stock Price Performance: +890%

Longboard Pharmaceuticals Nasdaq Listed
Source: Yahoo! Finance

  • Market Cap: $2.8 billion
  • Current Price: $20.45
  • Revenue Growth (Y/Y): 60%
  • Operating Expense Growth (Y/Y): 55%
  • Net Income: $8.2 million
  • Net Profit Margin: 4.1%
  • Earnings per Share (EPS): $0.07
  • EBITDA: $24.3 million
  • Effective Tax Rate: 18%
  • P/E Ratio: 29.3

Longboard Pharmaceuticals made strides in its drug development pipeline, securing positive trial results and attracting investor interest in the biotech sector.

NuScale Power Corporation (SMR) - YTD Stock Price Performance: +640%

NuScale plant
Source: Nuscale Power

  • Market Cap: $5.86B
  • Current Price: $23.3
  • Revenue Growth Quarterly (Y/Y): -93.17%
  • Operating Expense Growth Quarterly (Y/Y): -56.14%
  • Net Income: -17.46M
  • Net Profit Margin Quarterly (Y/Y): -1,235.89%
  • Earnings per Share (EPS): -0.18
  • EBITDA: -40.58M
  • Effective Tax Rate: -0.03%

Nuscale’s focus on modular nuclear power generation boosted its valuation as governments worldwide sought greener energy solutions.

ADMA Biologics Inc (ADMA) - YTD Stock Price Performance: +320%

ADMA laboratory
Source: ADMA Biologics

  • Market Cap: $4.50B
  • Current Price: $19
  • Revenue Growth Quarterly (Y/Y): 78.13%
  • Operating Expense Growth Quarterly (Y/Y): 25.38%
  • Net Income: 35.91M
  • Net Profit Margin Quarterly (Y/Y): 686.35%
  • Earnings per Share (EPS): 0.15
  • EBITDA: 41.58M
  • Effective Tax Rate: 2.29%
  • P/E Ratio: 69.20

The company’s expansion in plasma-derived therapeutics led to significant revenue gains and investor confidence in its sustainable growth strategy.

Avidity Biosciences Inc (RNA) - YTD Stock Price Performance: +279%

Avidity building
Source: Yahoo Finance

  • Market Cap: $4.15B
  • Current Price: $34
  • Revenue Growth Quarterly (Y/Y): -17.10%
  • Operating Expense Growth Quarterly (Y/Y): 69.52%
  • Net Income: -80.40M
  • Net Profit Margin Quarterly (Y/Y): -85.24%
  • Earnings per Share (EPS): -0.65
  • EBITDA: -97.42M

Avidity Biosciences capitalized on its groundbreaking RNA-based therapeutics, gaining strong momentum through clinical trial success and partnerships with leading pharmaceutical companies.

Janux Therapeutics Inc (JANX) - YTD Stock Price Performance: +480%

Janux laboratory
Source: Bloomberg

  • Market Cap: 3.68B
  • Current Price: $64
  • Revenue Growth Quarterly (Y/Y): -82.56%
  • Operating Expense Growth Quarterly (Y/Y): 174.42%
  • Net Income: -28.06M
  • Net Profit Margin Quarterly (Y/Y): -1,290.71%
  • Earnings per Share (EPS): -0.51
  • EBITDA: -35.33M

The company's advancements in precision oncology treatments drove significant gains in investor confidence and operational revenue, establishing Janux as a leader in biotech innovation.

Lumen Technologies Inc (LUMN) - YTD Stock Price Performance: +240%

Lumen Corporate Headquarters
Source: MarketWatch

  • Market Cap: $6.62B
  • Current Price: $6.4
  • Revenue Growth Quarterly (Y/Y): -11.54%
  • Operating Expense Growth Quarterly (Y/Y): -9.42%
  • Net Income: -148.00M
  • Net Profit Margin Quarterly (Y/Y): -114.49%
  • Earnings per Share (EPS): -0.13
  • EBITDA: 871.00M
  • Effective Tax Rate: 13.95%

Lumen leveraged its telecommunications expertise, witnessing growth driven by 5G and fiber-optic expansion projects, making it a favorite among mid-cap stocks in 2024.

AST SpaceMobile Inc (ASTS) - YTD Stock Price Performance: +392%

AST SpaceMobile Satellite
Source: AST Spacemobile

  • Market Cap: $6.91B
  • Current Price: $23.8
  • Revenue Q3: 1.10M
  • Operating Expense Growth Quarterly (Y/Y): 13.03%
  • Net Income: -171.95M
  • Net Profit Margin: -15.63K
  • Earnings per Share (EPS): -1.10
  • EBITDA: -51.00M
  • Effective Tax Rate: -0.21%

AST SpaceMobile's innovative satellite-based communication technology secured significant revenue growth and investment, cementing its position as a key player in space tech.

Hims & Hers Health Inc (HIMS) - YTD Stock Price Performance: +220%

hims&hers products
Source: Investopedia

  • Market Cap: $6.63B
  • Current Price: $31
  • Revenue Growth Quarterly (Y/Y): 77.1%
  • Operating Expense Growth Quarterly (Y/Y): 50.88%
  • Net Income: 75.59M
  • Net Profit Margin Quarterly (Y/Y): 663.47%
  • Earnings per Share (EPS): $0.43
  • EBITDA: 26.76M
  • P/E Ratio: 72.01

Hims & Hers solidified its position as a leading telehealth provider, with substantial growth driven by its diverse product portfolio and expanding user base in 2024.

In 2024, mid-cap companies have proven their value as powerful engines of innovation and growth. Their ability to adapt to shifting market trends and capitalize on emerging opportunities highlights their strategic importance in the investment landscape. As they continue to evolve, these companies remain a compelling choice for investors seeking a dynamic balance of growth potential and financial stability.

FAQs on Top Performing Mid Cap Stocks 2024

Which stocks are expected to rise in 2024?

Stocks with strong fundamentals, innovative technologies, or exposure to growing industries such as renewable energy, healthcare, and AI are expected to rise in 2024.

Which are the best stocks for the next 5 years?

Stocks in sectors like clean energy, biotech, and advanced technology often hold long-term potential. Examples include companies innovating in nuclear energy, genetic testing, and telecommunications.

What stocks to buy for the next 10 years?

Long-term investments often favor sectors with high growth potential, such as healthcare, renewable energy, and technology-driven solutions.

How to choose mid-cap stocks?

Evaluate revenue and profit growth, industry trends, competitive positioning, and financial health when selecting mid-cap stocks.

Is it a good time to invest in mid-cap stocks?

Mid-cap stocks can offer strong growth potential, especially during periods of market recovery or innovation-driven industry shifts, making 2024 a favorable time for investment.

What are the top 10 small-cap stocks?

The top small-cap stocks are typically highlighted by their growth potential and market niche. Examples include companies excelling in technology and biotech sectors.

What is mid-cap strategy?

A mid-cap strategy focuses on identifying companies with growth potential that are neither too large nor too small, balancing stability and higher growth opportunities.

Are mid-cap stocks a good investment now?

Yes, mid-cap stocks can be a good investment in 2024 due to their ability to adapt to market trends while offering potential for substantial growth.

What is the M-cap strategy?

The M-cap strategy involves diversifying investments across market capitalizations (small-cap, mid-cap, and large-cap) to manage risk and maximize returns.

What are examples of mid-cap stocks?

Examples of mid-cap stocks in 2024 include Nuscale Power (SMR), Avidity Biosciences (RNA), and Janux Therapeutics (JANX).

Other Ways to Profit from Mid Cap Stocks

Using event-driven trading to find the best entry and exit points provides many benefits long-term stock holding cannot:

  • Rapid gains
  • Outsized gains
  • Access to your capital
  • Reduced exposure to macroeconomic events
  • Reduced exposure to competition
  • A consistent, repeatable strategy

Event-driven trading identifies stocks being catalyzed by events. This enables traders to use AI stock trading to identify stock set to move higher quickly. For most of the year, stocks stay in a trading range. When events happen, share prices can move 20%, 50%, even 100% in just a short time, enabling investors to capitalize on these rapid movements. 

Find the Best Investments 1,800 Times Faster With LevelFields AI

LevelFields

Ready to transform the way you trade? With LevelFields, you gain access to cutting-edge analytics that empower you to find better investments 1,800 times faster.

Our platform analyzes over 1.8 million market events each month, ensuring you act on facts, not opinions. Don’t leave your trading decisions to chance—equip yourself with the tools to make informed, data-driven investments.

Sign up today and start turning market insights into profits.

Join LevelFields now to be the first to know about events that affect stock prices and uncover unique investment opportunities. Choose from events, view price reactions, and set event alerts with our AI-powered platform. Don't miss out on daily opportunities from 6,300 companies monitored 24/7. Act on facts, not opinions, and let LevelFields help you become a better trader.

Find Better Investments 1800x Faster

AI scans for events proven to impact stock prices, so you don't have to.

LEARN MORE

Free Trial: Signup for 1 Free Alert Per Week

Add your email to get alerts & the report.

Get 1 free alert per week via email

Upgrade if you want more or platform access

We'll also send you a free report

or Click Here to get full access now

By clicking “Accept All Cookies”, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts. View our Privacy Policy for more information.